Protocol for the development and validation of a Polypharmacy Assessment Score.

Jung Yin TsangMatthew SperrinThomas BlakemanRupert A PayneDarren M Ashcroft

Published in: Diagnostic and prognostic research (2024)

Developing a cross-cutting measure of polypharmacy may allow healthcare professionals to prioritise and risk stratify patients with polypharmacy using unusual levels of prescribing. This would be an improvement from current approaches of either using simple cutoffs or narrow prescribing criteria.

Keyphrases

adverse drug
primary care
randomized controlled trial
emergency department
electronic health record